MedPath

Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"

Active, not recruiting
Conditions
Squamous Cell Carcinoma
Registration Number
NCT01976468
Lead Sponsor
University of Zurich
Brief Summary

The investigators hypothesize that a low number of SCC in OTR will metastasize.

Detailed Description

In a large international multicenter prospective observational study a total number of 1000 OTR (organ transplant recipients) with a histologically proven cutaneous SCC (squamous cell carcinoma) will be included in 10 centers and followed during 2 years to establish the cumulative incidence of metastases in OTR with cutaneous SCC.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SCC metastasis detectiontwo years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Leiden University Medical Center

🇳🇱

Leiden, Netherlands

University Hospital Zurich, Division of Dermatology

🇨🇭

Zurich, ZH, Switzerland

Leiden University Medical Center
🇳🇱Leiden, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.